CPHI_OUT_1 [2025-04-02 08:24:38 -0400] 2923 Bytes | 753 tokens | Cum: 753 tkns (9.41% of 8k)
==========================================================================

We're scouting for winners today. Its 8:24:38 AM on Wed Apr 02, 2025 -0400 and I'm looking at China Pharma (CPHI) up to 0.2849 from 0.245048

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

--- COMPANY PROFILE ---
Company: China Pharma (CPHI)
IPO: 2002-04-14 (22 Years Ago)
Market Cap: $4,717,998
Shares Outstanding: 19,250,000
Industry: PHARMACEUTICAL PREPARATIONS
Exchange: XASE
Description: China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Here's the first list of news for China Pharma:

C1 - Dec-18-24 08:30AM - China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville
C2 - Dec-13-24 08:00AM - China Pharma Announces the Entry of "At-The-Market" Equity Offering
C3 - Aug-19-24 08:00AM - China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025
C4 - Feb-23-24 04:05PM - China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split
C5 - Nov-29-23 08:00AM - China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device
C6 - Aug-23-23 07:34PM - Is China Pharma Holding (CPHI) A Hidden Gem or A Value Trap?
C7 - Aug-09-23 08:30AM - China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs
C8 - Feb-24-23 04:05PM - China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on China Pharma (CPHI)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

CPHI_OUT_3 [2025-04-02 08:24:45 -0400] 1098 Bytes | 305 tokens | Cum: 1060 tkns (13.25% of 8k)
==========================================================================

Showing C3 (chunk 1 of 6): C3:
**China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025**
Date: Aug-19-24 08:00AM
Source: (PR Newswire)
URL: https://www.prnewswire.com/news-releases/china-pharma-holdings-inc--expects-to-launch-its-dry-eye-disease-therapeutic-device-in-the-first-quarter-of-2025-302225097.html

HAIKOU, China,Aug. 19, 2024/PRNewswire/ --China Pharma Holdings, Inc.(NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that through Hainan Helpson Medical and Biotechnology Co., Ltd. ("Helpson"), our wholly owned subsidiary, it expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 inChina.

InChina, the incidence of dry eye disease is about 21%-30%, second only to myopia. According to

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CPHI_OUT_5 [2025-04-02 08:24:46 -0400] 605 Bytes | 164 tokens | Cum: 1341 tkns (16.76% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-12T21:18:05Z - 12 Health Care Stocks Moving In Wednesday's After-Market Session - BioSig Technologies (NASDAQ:BSGM)...
A2 - 2025-03-03T14:43:59Z - BB's Stock Haven : Cphi .21 expects to launch its Dry Eye D......

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CPHI_OUT_7 [2025-04-02 08:24:52 -0400] 1098 Bytes | 332 tokens | Cum: 1675 tkns (20.94% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Wednesday's After-Market Session - BioSig Technologies (NASDAQ:BSGM), Aditxt (NASDAQ:ADTX)**Date: 2025-03-12Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44290644/12-health-care-stocks-moving-in-wednesdays-after-market-sessionGainers TuHURA Biosciences HURA stock increased by 17.4% to $2.46 during Wednesday's after-market session. The market value of their outstanding shares is at $104.0 million. SenesTech SNES stock moved upwards by 16.23% to $2.65. The market value of their outstanding shares is at $2.7 million. As per the press release, Q4 earnings came out today. BioSig Technologies BSGM stock increased by 12.64% to $0.8. The market value of their outstanding shares is at $18.4 million. Scienture Holdings SCNX shares moved upwards by 12.41% to $1.46. The company's marke

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CPHI_OUT_9 [2025-04-02 08:24:53 -0400] 1019 Bytes | 303 tokens | Cum: 2098 tkns (26.22% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-01-29T12:56:17Z - Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
B2 - 2023-12-26T13:00:58Z - Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket
B3 - 2023-11-29T19:02:04Z - Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B4 - 2023-11-29T14:48:31Z - Nasdaq Surges Over 100 Points; US Economy Expands Faster Than Expected
B5 - 2023-08-23T17:02:53Z - Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B6 - 2023-08-23T12:34:21Z - Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CPHI_OUT_11 [2025-04-02 08:24:59 -0400] 1102 Bytes | 301 tokens | Cum: 2401 tkns (30.01% of 8k)
==========================================================================

Showing B1 (chunk 1 of 2): B1:
**Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/01/36822621/why-zim-integrated-shipping-services-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20.
ZIM Integrated Shipping Services shares climbed 9.2% to $14.72 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers

NovaBay Pharmaceuticals, Inc. (NYSE: NBY) gained 71.3% to $0.2810 in pre-market trading after gaining around 8% on Friday. NovaBay Pharmaceuticals and Sonoma Pharmaceuticals recently agreed to market Avenova-branded products in the European Union.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CPHI_OUT_13 [2025-04-02 08:25:00 -0400] 1061 Bytes | 285 tokens | Cum: 2803 tkns (35.04% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-31 10-K ITEM 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER.

The statements contained in this report with respect to our financial condition, results of operations and business that are not historical facts are forward-looking statements. Forwa...

S2 - 2024-12-13 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On December 12, 2024, China Pharma Holdings Inc.. (the Company ) entered into that certain securities purchase agreement (the SPA ) with certain institutional investor (the Investor ) with respect to an at-the-market offerin...

S3 - 2024-11-13 10-Q PART I FIN INFO

Item 1. Fin Stmnts

CHINA PHARMA HOLDINGS, INC. & SUBSIDIARIES

Condensed Cons Balance Sheets as of September 30, 2024 and December 31, 2023 (Unaudited) 2 Condensed Cons Stmnts of Oper and Comprehensive Loss ...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CPHI_OUT_15 [2025-04-02 08:25:05 -0400] 1098 Bytes | 235 tokens | Cum: 3040 tkns (38.00% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The statements contained in this report with respect to our financial condition, results of operations and business that are not historical facts are forward-looking statements. Forward-looking statements can be identified by the use of forward-looking terminology, such as anticipate, believe, expect, plan, intend, seek, estimate, project, could, or the negative thereof or other variations thereon, or by discussions of strategy that involve risks and uncertainties. Management wishes to caution the readers that any such forward-looking statements contained in this report reflect our current beliefs with respect to future events and involve known and unknown risks, uncertainties and other factors, including, but not limited to, economic, competitive, regulatory, technological, key employees,

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CPHI_OUT_17 [2025-04-02 08:25:16 -0400] 4157 Bytes | 1189 tokens | Cum: 4343 tkns (54.29% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------+----------------------+------------------------+------------------------+
| Volume: 479,599 | Perf Month: 25.67% | Option/Short: No / Yes | Sales Y/Y TTM: -28.76% |
+-------------------+----------------------+------------------------+------------------------+
| Avg Volume: 1.12M | Perf Quarter: 16.75% | Short Float: 2.11% | ROE: -75.07% |
+-------------------+----------------------+------------------------+------------------------+
| Rel Volume: 0.41 | Index: - | Short Ratio: 0.18 | ROI: -59.63% |
+-------------------+----------------------+------------------------+------------------------+
| RSI (14): 49.24 | Market Cap: 7.99M | Short Interest: 0.20M | Sales Surprise: - |
+-------------------+----------------------+------------------------+------------------------+
| ATR (14): 0.03 | Shs Outstand: 17.86M | Beta: 0.84 | EPS Surprise: - |
+-------------------+----------------------+------------------------+------------------------+
| SMA20: -3.49% | Shs Float: 9.38M | Sales Q/Q: -39.00% | P/E: - |
+-------------------+----------------------+------------------------+------------------------+
| SMA50: 6.80% | Inst Own: 0.90% | Sales past 5Y: - | Earnings: - |
+-------------------+----------------------+------------------------+------------------------+
| SMA200: 9.58% | Insider Own: 51.28% | Employees: - | |
+-------------------+----------------------+------------------------+------------------------+
| Perf Week: -6.33% | Insider Trans: 0.00% | Debt/Eq: 0.61 | |
+-------------------+----------------------+------------------------+------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 5544620.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -4744146.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.245048
Average Volume: 647199.73
30-Day High: 0.2949
30-Day Low: 0.195

[Detailed Financials: Q3 2024]
- Total Assets: $13,465,610.0
- Total Liabilities: $6,937,361.0
- Total Equity: $6,528,249.0
- Current Assets: $3,738,977.0
- Current Liabilities: $4,760,209.0

[Income Statement: Q3 2024]
- Revenue: $1,100,152.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.06

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-30,889

[Detailed Financials: Q2 2024]
- Total Assets: $14,261,233.0
- Total Liabilities: $6,852,711.0
- Total Equity: $7,408,522.0
- Current Assets: $3,972,978.0
- Current Liabilities: $4,712,035.0

[Income Statement: Q2 2024]
- Revenue: $924,943.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.09

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-672,262
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

CPHI_OUT_19 [2025-04-02 08:25:17 -0400] 676 Bytes | 167 tokens | Cum: 4769 tkns (59.61% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

CPHI_IN_21 [2025-04-02 08:25:17 -0400] 126 Bytes | 29 tokens | Cum: 4805 tkns (60.06% of 8k)
==========================================================================

====================================
[2025-04-02 08:25:17] # Analysis Completed
Elapsed Time: 39.39 seconds